Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an American-based oncology-focused, clinical stage biotechnology company, today announced it has selected Hamilton, Ontario-based Centre for Probe Development and Commercialization (CPDC), a well-respected GMP manufacturing organization specializing in radiopharmaceuticals, as a supplier of the company’s lead phospholipid drug conjugate To read more, please click here
Innovation Showcase highlights growing impact of student-entrepreneurs
Canada needs a strategy to reach its biotech potential
Reliq Health Technologies Inc., a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has signed an agreement with Hamilton Health Sciences and McMaster University in Hamilton, Ontario to pilot its remote patient monitoring and care collaboration solution. The pilot is expected to […]
Start-up Turnstone Biologics Closes USD $41M Financing
Oct-2016
IBM Canada is looking for commercial space for ‘long-term’ investment in downtown Hamilton
St. Joseph’s Healthcare Hamilton is now one of two hospitals in Canada to receive a prominent accreditation from the Royal College of Physicians and Surgeons of Canada for training physicians and surgeons in kidney transplantation.
Aug-2016
The Ontario Chamber of Commerce (OCC) and Hamilton Chamber of Commerce are suggesting a different approach to fixing the province’s health care system and putting patients first. In a report released yesterday, the organization is calling on the provincial government to turn its focus from budget cuts to empowering the health care system to become […]
Franhaufer BEAM Center Secures $12m in Federal Funding
Province of Ontario investing Over $26 Million in Health Care for Hamilton